Aurora Therapeutics, cofounded by Nobel Prize–winning scientist Jennifer Doudna, plans to use gene editing and a new FDA ...
Potentially more than 90% of Alzheimer's disease cases would not occur without the contribution of a single gene (APOE), ...
CS-101 is Shanghai-based CorrectSequence's lead candidate, which it is developing for treating sickle-cell disease and ...
In the battle against type 1 diabetes (T1D), one researcher at the Medical University of South Carolina (MUSC) is leading a ...
This month, VacZine Analytics, a specialist publisher in healthcare commercial analysis, releases a brand-new situation ...
Kavita Mehta is pinning her hopes on 2026 for a cure to a major blood disorder, following a breakthrough gene-editing ...
As CRISPR moves from lab success to real-world medicine, 2026 will test whether these revolutionary gene-editing therapies ...
A live webcast of the presentation will be available on the "Events & Presentations" page in the Investors section of the ...
Abu Dhabi successfully completes its first gene therapy for genetic blood disorders, revolutionizing treatment approaches for ...
Abu Dhabi introduces a revolutionary gene therapy for hemoglobinopathies, utilizing CRISPR-Cas9 technology. Explore how this ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results